Differential treatment benefit of platelet glycoprotein IIb/IIIa inhibition with percutaneous coronary intervention versus medical therapy for acute coronary syndromes: exploration of methods.

Differential treatment benefit of platelet glycoprotein IIb/IIIa inhibition with percutaneous coronary intervention versus medical therapy for acute coronary syndromes: exploration of methods. Circulation. 2004 Feb 10; 109(5):641-6.

View in: PubMed

subject areas

Acute Disease
Aged
Combined Modality Therapy
Coronary Disease
Female
Humans
Male
Middle Aged
Myocardial Revascularization
Patient Selection
Platelet Glycoprotein GPIIb-IIIa Complex
Randomized Controlled Trials as Topic
Research Design
Syndrome
Treatment Outcome

authors with profiles

Robert Harrington